{"cmr":"ca-cm-kg/TSX/HLS","since":null,"total":22,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-11-03","event_type":"newswire_release","title":"HLS Therapeutics Partners with Bayer to Commercialize VERQUVO® in Canada","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-partners-with-bayer-to-commercialize-verquvo-r-in-canada-820025198.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lrbRIEBcqIqEBu5Xy3Li6DVhWlFNumNNTscVy7UMty_Vsa7ptz8cne5UvtCcvwc2g4vvCuaaXYvPe6dyL1lsBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-10-29","event_type":"financial_statement","title":"HLS Therapeutics to Host Q3 2026 Financial Results Conference Call","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-host-q3-2026-financial-results-conference-call-893495598.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fE1CTl9nLrmx6QdprYs8qq-ENCh7-aT2ZySuKbydytGhsYKyMNmj4t0bEZiOy47gVY6KbO5QLqojsKscrfs0Cg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-10-29","event_type":"financial_statement","title":"HLS Therapeutics to Host Q3 2026 Financial Results ...","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/fr/news-releases/hls-therapeutics-to-host-q3-2026-financial-results-conference-call-893495598.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"stJRvrvpLvIPHVtBQ13R6i1Uu0g2ONH1WDvg8Tn765g9Wp06XuJXe2FN2nWFTuuxMsjTEEdFqKMDedSCvA7bBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-10-27","event_type":"newswire_release","title":"HLS Therapeutics to Present at the Planet MicroCap Toronto Conference","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-present-at-the-planet-microcap-toronto-conference-833075608.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"H7pZasggmG5_zPovt8G7Ouq2khMjPgB5hwwiG9cVroN5NlhiY-qHj7CMGX-xD4e79ITUeXoxHam2CpMHXfx7Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-10-01","event_type":"newswire_release","title":"HLS Therapeutics Announces Board of Directors Changes","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-board-of-directors-changes-890503683.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UZYgPZAP2_gomoT_ESeJAaUU2-GucLPDrpg9yhQRA_aegWlLT0JM0KUfS2H5MK5vwad-ttgV-qpI8iczcfkdBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-09-24","event_type":"corporate_action","title":"HLS Therapeutics Increases Normal Course Issuer Bid","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-increases-normal-course-issuer-bid-810204776.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6ElmXGcPNuKTOzlHw8Sgv8FhwMuwaYInR6gYIGe1s5rXuGi3isiskk7sG48ol-sl0perEFqk2wjHYgpP3jCfBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-08-12","event_type":"financial_statement","title":"HLS Therapeutics Announces Q2 2026 Financial Results","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-q2-2026-financial-results-853589342.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"U3FOHZushd1A3uvVEs-0CHtcw8oA-8Bv4p20JiWoxjA99z2ZL1CwV9fs1SM633-n8c6zJFz2exfgokxaW5b8BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-08-05","event_type":"newswire_release","title":"HLS Therapeutics Provides Update on NILEMDO™ Market Access","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-provides-update-on-nilemdo-tm-market-access-801421109.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_wAmfpczF7JHSi385NPdj7ZdfDtMCOQNVKVF-1n3JiXxmtd2cR9os_BY01HpcciwirStXMYkN8onncRLDJjiDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-07-29","event_type":"financial_statement","title":"HLS Therapeutics to Host Q2 2026 Financial Results Conference Call","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-host-q2-2026-financial-results-conference-call-889362527.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ti1gp0TXUUIH2PTxvS919ZEpXiuEk3DYAJcA8QfPW2TkI8OshQ3XD-m2TRybLPLQnngE7IpBiVJxhJrRJsBICA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-06-26","event_type":"agm_record_date","title":"[agm] stated date 2026-06-26: TORONTO , June 26, 2026 /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS ), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and car","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-reports-annual-meeting-results-841046975.html","read_by":"read by Gemini","state":"filled","detail":"stated agm date 2026-06-26","statement_date":"2026-06-26","auditor_named":"Ernst & Young LLP","going_concern":"no","extract_read_by":"read by ChatGPT (batch)","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TTpuURIOZNXqJsz4sqfGaM_eP3zshOjrvs6ipTEbvUtQ3XBD6G7OGTKcurjiTDyymx70iUGfGNQWPPgUqB6-Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-06-26","event_type":"financial_statement","title":"HLS Therapeutics Reports Annual Meeting Results","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-reports-annual-meeting-results-841046975.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"KJjhu-0_zJD1aMKTOkAsdq05XIGTxq3yYuzst5BlCcQEPoWyc7lDthXq3vrDpRWnn89Ut3DNKnVMySrP69tSAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-06-23","event_type":"corporate_action","title":"HLS Therapeutics Announces Normal Course Issuer Bid","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-normal-course-issuer-bid-879523621.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vGDqmxmjUJBIFBOe0g_J_KKA3-1g1Pkt_YDHvtIjJ092eOziqe7hO_ys1C6IKroYSTH-UoyDJeMuyy88C-MiAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-05-15","event_type":"financial_statement","title":"HLS Therapeutics Announces Q1 2026 Financial Results","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-q1-2026-financial-results-867728820.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uzT5__C_yaqaPUVnUTk5_AOapObIe2b8F9Dkebg78TDN_HEMBC91yp01ThIMmaF0pjQMZk3YN4aG2VONQVvmCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-05-01","event_type":"financial_statement","title":"HLS Therapeutics to Host Q1 2026 Financial Results Conference Call","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-host-q1-2026-financial-results-conference-call-852321328.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-5xnSKIQrs8S0-mQU61FxkuR8ODpgQtcC4l0W-kYLlrG2leKMv1aB8sVHUkuCpgnxFCihm9u3QvhYCS_CqvHCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-04-14","event_type":"newswire_release","title":"HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-present-at-the-2026-bloom-burton-amp-co-healthcare-investor-conference-869791509.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3v5UO3FkeiL-27ZSdRTQnLRNIVTi4FpIBHM1b3ZKmjHu6M-v8j3LkrO5A0BczjCncW_wcb-p2l-OP2AxrDo2Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-03-12","event_type":"financial_statement","title":"HLS Therapeutics Announces Fiscal 2025 Financial Results","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-fiscal-2025-financial-results-899721800.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"B4QkZh1HA7XTGchZ-dyfId6Z-RbwsTkCCvyS3ACdlow9_FLyZHfpcHFuOKjSavq7DvfyMKm3jIMEw8iEXWEyCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-03-05","event_type":"newswire_release","title":"HLS Therapeutics Announces NILEMDO™ (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-nilemdotm-bempedoic-acid-is-now-available-in-canada-for-the-reduction-of-ldl-cholesterol-in-patients-at-risk-of-cardiovascular-disease-848090021.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_xHzq3rUUq_qYmD9GTZ-qVNvOTlg7QJx4xiz92AVcFG0bD8NmIBf58_lM5_yvuwpkpyDoymtJJUDYI4YwK5BBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2026-02-26","event_type":"financial_statement","title":"HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-host-fiscal-2025-financial-results-conference-call-863942631.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ykWGQcwnFTHnDojuEkuRQ6_m8Xi5c055y-sb_wmB-NEznqnjT5ITd3qZK3PD6f-08djLd5M1XbC1XIVXDtcgAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2025-11-18","event_type":"newswire_release","title":"HLS Therapeutics Announces Health Canada Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-health-canada-approval-of-nilemdo-r-for-the-reduction-of-ldl-cholesterol-in-canadians-at-risk-of-cardiovascular-disease-837557792.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rCDeJdN-XFby1Yz9_Z2n9lj56w8hL51T7srF8JgQ0Bk4fheG40i592KCN9bFh7TlINOUv2cU0dYBuRBAxpmgCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2025-11-13","event_type":"financial_statement","title":"HLS Therapeutics Announces Q3 2025 Financial Results","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-announces-q3-2025-financial-results-864647776.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RnzL9Wv0s5o8Jvc_FzOsJXGwXAe0NOBKe2PVHArKyBACkpo5JNF6JpwSPco-Jt_wwSqx8rMO9d_A215d1ZgmDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2025-10-30","event_type":"financial_statement","title":"HLS Therapeutics to Host Q3 2025 Financial Results Conference Call","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-to-host-q3-2025-financial-results-conference-call-845401552.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zjZ-_G_cBLoBO96WJIiIjPh9irQBV8XzTM6SNB9idtKLJgOuPkfuA-JeJ5iyGW4pBm1bCoeWxXqXZPLF1h35Aw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/HLS","date":"2025-10-14","event_type":"newswire_release","title":"HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/hls-therapeutics-and-amarin-collaborate-on-presenting-reduce-it-r-and-epa-mechanistic-data-at-the-canadian-cardiovascular-congress-891705084.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XfvUoEGuUjXD3CtKXqYTGUflTXcYe_YlxpDUSRm4TnXxWKGC_k_RL7InbEZjIlWPj9OpcUjOO-eNOB3nAJEhDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}